State Street Corp Nurix Therapeutics, Inc. Transaction History

State Street Corp

  • $2.36 Trillion
  • Q1 2025

A detailed history of State Street Corp transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 2,861,220 shares of NRIX stock, worth $27.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,861,220
Previous 2,803,260 2.07%
Holding current value
$27.8 Million
Previous $52.8 Million 35.64%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$11.88 - $20.15 $688,564 - $1.17 Million
57,960 Added 2.07%
2,861,220 $34 Million
Q4 2024

Feb 14, 2025
BUY
$18.64 - $28.14 $8.05 Million - $12.2 Million
431,989 Added 18.22%
2,803,260 $52.8 Million
Q3 2024

Nov 14, 2024
SELL
$18.93 - $25.69 $6.38 Million - $8.66 Million
-337,262 Reduced 12.45%
2,371,271 $53.2 Million
Q2 2024

Aug 14, 2024
SELL
$12.02 - $21.3 $250,052 - $443,103
-20,803 Reduced 0.76%
2,708,533 $56.5 Million
Q1 2024

May 15, 2024
BUY
$7.77 - $15.66 $14 Million - $28.3 Million
1,808,014 Added 196.24%
2,729,336 $40.1 Million
Q4 2023

Feb 14, 2024
SELL
$4.25 - $10.71 $3.62 Million - $9.13 Million
-852,746 Reduced 48.07%
921,322 $9.51 Million
Q3 2023

Nov 14, 2023
SELL
$7.86 - $10.08 $1.19 Million - $1.53 Million
-151,658 Reduced 7.88%
1,774,068 $13.9 Million
Q2 2023

Aug 14, 2023
SELL
$8.7 - $13.28 $2.69 Million - $4.11 Million
-309,552 Reduced 13.85%
1,925,726 $19.2 Million
Q1 2023

May 15, 2023
SELL
$8.56 - $13.26 $2.33 Million - $3.62 Million
-272,709 Reduced 10.87%
2,235,278 $19.8 Million
Q4 2022

Feb 14, 2023
BUY
$9.86 - $14.59 $1.93 Million - $2.86 Million
195,763 Added 8.47%
2,507,987 $27.5 Million
Q3 2022

Nov 15, 2022
BUY
$12.33 - $19.81 $2.41 Million - $3.87 Million
195,453 Added 9.23%
2,312,224 $30.1 Million
Q2 2022

Aug 15, 2022
SELL
$7.88 - $14.82 $1.46 Million - $2.75 Million
-185,773 Reduced 8.07%
2,116,771 $26.8 Million
Q1 2022

May 16, 2022
BUY
$12.94 - $29.65 $9.64 Million - $22.1 Million
744,832 Added 47.82%
2,302,544 $32.3 Million
Q4 2021

Feb 14, 2022
SELL
$26.43 - $34.5 $1.99 Million - $2.6 Million
-75,419 Reduced 4.62%
1,557,712 $45.1 Million
Q3 2021

Nov 15, 2021
SELL
$22.71 - $36.69 $5.14 Million - $8.3 Million
-226,337 Reduced 12.17%
1,633,131 $48.9 Million
Q2 2021

Aug 16, 2021
BUY
$24.21 - $35.89 $11.7 Million - $17.3 Million
481,606 Added 34.95%
1,859,468 $49.3 Million
Q1 2021

May 17, 2021
BUY
$26.98 - $50.17 $25 Million - $46.5 Million
926,630 Added 205.36%
1,377,862 $42.8 Million
Q4 2020

Feb 16, 2021
BUY
$22.85 - $48.44 $7.3 Million - $15.5 Million
319,559 Added 242.69%
451,232 $14.8 Million
Q3 2020

Nov 10, 2020
BUY
$16.05 - $34.91 $2.11 Million - $4.6 Million
131,673 New
131,673 $4.6 Million

Others Institutions Holding NRIX

# of Institutions
182
Shares Held
74.4M
Call Options Held
56.9K
Put Options Held
7.9K
View Full List

About Nurix Therapeutics, Inc.

NRIX Quotes by TradingView
  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $458M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email